APOBEC3B Promotes SARS-CoV-2 Through Activation of PKR/eIF2⍺ and AMPD2 Dysregulation
Viruses · 28.08.2025 · 17 (9) · 1176
DOI: 10.3390/v17091176 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 28.08.2025. Verfasst von Benjamin Fixman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular and Computational Biology, Department of Biological Sciences, University of Southern, Los Angeles, CA 90089, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, eIF-2 Kinase, Eukaryotic Initiation Factor-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
APOBEC3B (A3B) has been implicated in host–virus interactions, but its role in SARS-CoV-2 infection is unclear. Here, we demonstrate that A3B is overexpressed in bronchoalveolar lavage fluid (BALF) cells from severe COVID-19 patients compared to those with mild disease. A3B knockdown in Caco-2 cells significantly reduces SARS-CoV-2 infectivity, likely through attenuation of the PKR-mediated integrated stress response, a pathway proposed to promote SARS-CoV-2. Single-cell RNA sequencing (scRNA-seq) data suggest that BALF cells from severe COVID-19 patients exhibit a repressed state for cellular translation, potentially mediated by eIF2α phosphorylation. However, in A549-ACE2 cells, SARS-CoV-2 does not activate PKR, but A3B knockdown still reduces SARS-CoV-2 infectivity, suggesting an alternative mechanism of action in different cellular contexts. To further investigate A3B’s role in severe COVID-19, we employed Geneformer, a transformer-based machine learning model, which predicted that A3B knockout would perturb AMPD2 (adenosine monophosphate deaminase 2), a key enzyme in purine metabolism and immune regulation. We validated this prediction using bulk RNA-seq and clinical scRNA-seq data, confirming that AMPD2 expression is downregulated in severe COVID-19 but restored upon A3B knockdown. Together, these findings suggest that A3B plays a proviral role in SARS-CoV-2 infection by modulating translational control and immune regulatory networks, warranting further studies to elucidate the underlying mechanistic details.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular and Computational Biology, Department of Biological Sciences, University of Southern, Los Angeles, CA 90089, USA.
- Department of Biological Chemistry, School of Medicine, University of California Irvine, Irvine, CA 92697, USA.
- Department of Molecular Microbiology and Immunology, The Hastings and Wright Laboratories, Keck School of Medicine, University of Southern California, Los Angeles, CA 90089, USA.
- Center of Excellence in NanoBiophysics, Los Angeles, CA 90089, USA.
- Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90089, USA.
ORCID-Profile: Benjamin Fixman, Lavanya Manjunath, Philip Sell, Connor Qiu, Hanjing Yang, Rémi Buisson
Förderung
- NIH HHS
- NIAID NIH HHS
- NIEHS NIH HHS
- NCI NIH HHS
- UCI Division of Graduate Studies
- NIH
- American Cancer Society
- UCI Chao Family Comprehensive Cancer Center Anti-Cancer Challenge
Zitieren
APA
Fixman, B., Manjunath, L., Sell, P., Wang, S., Margaryan, T., Qiu, C., Yang, H., Buisson, R., & Chen, X. S. (2025). APOBEC3B Promotes SARS-CoV-2 Through Activation of PKR/eIF2⍺ and AMPD2 Dysregulation. Viruses, 17(9), 1176. https://doi.org/10.3390/v17091176
Vancouver
Fixman B, Manjunath L, Sell P, Wang S, Margaryan T, Qiu C, et al. APOBEC3B Promotes SARS-CoV-2 Through Activation of PKR/eIF2⍺ and AMPD2 Dysregulation. Viruses. 2025;17(9):1176. doi:10.3390/v17091176
BibTeX
@article{Fixman2025,
author = {Fixman, Benjamin and Manjunath, Lavanya and Sell, Philip and Wang, Shanshan and Margaryan, Tamara and Qiu, Connor and Yang, Hanjing and Buisson, Rémi and Chen, Xiaojiang S},
title = {APOBEC3B Promotes SARS-CoV-2 Through Activation of PKR/eIF2⍺ and AMPD2 Dysregulation},
journal = {Viruses},
year = {2025},
volume = {17},
number = {9},
pages = {1176},
doi = {10.3390/v17091176}
}
EUVIMED